RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Evofem Biosciences Stock

Evofem Biosciences Net Income 2024

Evofem Biosciences Net Income

-16.37 M USD

Ticker

EVFM

ISIN

US30048L1044

WKN

A2JBZC

In 2024, Evofem Biosciences's profit amounted to -16.37 M USD, a -132.75% increase from the 50 M USD profit recorded in the previous year.

The Evofem Biosciences Net Income history

YEARNET INCOME (undefined USD)
2026e-42.3
2025e-23.49
2024e-16.37
202350
2022-78.01
2021-206.24
2020-142.31
2019-80.03
2018-125.78
2017-9.99
2016-13.02
2015-43.16
2014-10.82
2013-15.02
2012-7.83

Evofem Biosciences Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Evofem Biosciences, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Evofem Biosciences from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Evofem Biosciences’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Evofem Biosciences. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Evofem Biosciences’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Evofem Biosciences’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Evofem Biosciences’s growth potential.

Evofem Biosciences Revenue, EBIT and net profit per share

DateEvofem Biosciences RevenueEvofem Biosciences EBITEvofem Biosciences Net Income
2026e303.05 M undefined-67.18 M undefined-42.3 M undefined
2025e219.65 M undefined-49.02 M undefined-23.49 M undefined
2024e127.34 M undefined-14.57 M undefined-16.37 M undefined
202318.22 M undefined-17.85 M undefined50 M undefined
202216.84 M undefined-69.72 M undefined-78.01 M undefined
20218.24 M undefined-166.8 M undefined-206.24 M undefined
2020446,000 undefined-103.52 M undefined-142.31 M undefined
20190 undefined-52.74 M undefined-80.03 M undefined
20180 undefined-77.64 M undefined-125.78 M undefined
20170 undefined-10.04 M undefined-9.99 M undefined
20160 undefined-12.04 M undefined-13.02 M undefined
20150 undefined-42.05 M undefined-43.16 M undefined
20140 undefined-9.59 M undefined-10.82 M undefined
20130 undefined-14.42 M undefined-15.02 M undefined
2012100,000 undefined-5.74 M undefined-7.83 M undefined

Evofem Biosciences stock margins

The Evofem Biosciences margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Evofem Biosciences. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Evofem Biosciences.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Evofem Biosciences's sales revenue. A higher gross margin percentage indicates that the Evofem Biosciences retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Evofem Biosciences's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Evofem Biosciences's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Evofem Biosciences's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Evofem Biosciences. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Evofem Biosciences's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Evofem Biosciences Margin History

Evofem Biosciences Gross marginEvofem Biosciences Profit marginEvofem Biosciences EBIT marginEvofem Biosciences Profit margin
2026e64.26 %-22.17 %-13.96 %
2025e64.26 %-22.32 %-10.69 %
2024e64.26 %-11.44 %-12.86 %
202364.26 %-97.96 %274.43 %
202273.78 %-414.11 %-463.35 %
202150.81 %-2,023.3 %-2,501.69 %
202017.49 %-23,211.66 %-31,907.85 %
201964.26 %0 %0 %
201864.26 %0 %0 %
201764.26 %0 %0 %
201664.26 %0 %0 %
201564.26 %0 %0 %
201464.26 %0 %0 %
201364.26 %0 %0 %
201264.26 %-5,740 %-7,830 %

Evofem Biosciences Aktienanalyse

What does Evofem Biosciences do?

Evofem Biosciences Inc is a biochemistry company based in San Diego, California, that focuses on developing products to enhance women's sexual and reproductive health. The company, founded in 2001 by a group of scientists and doctors, aims to provide women with more effective methods of contraception and treatment for infectious diseases. Evofem Biosciences is an innovative biotech company specializing in the development of women's lifestyle and healthcare products, with a focus on birth control and the prevention of sexually transmitted infections (STIs). These products are developed using the company's own technology, which is based on a novel chemical binder and has proven to be particularly effective and safe. Evofem Biosciences' products are used by women around the world to protect themselves against unintended pregnancy and STIs. In the United States, the company is known as the only one that exclusively focuses on the development and marketing of women's products. The current products of Evofem Biosciences primarily focus on contraception. For example, the company has developed and markets a vaginal gel called "Phexxi." Phexxi is a hormone-free contraceptive that is used as needed to block sperm from reaching the egg. It was designed to provide women with a new option for contraception when hormonal contraceptives are not suitable due to side effects or other reasons. Another product in Evofem Biosciences' pipeline is an antimicrobial gel developed for the prevention of STIs, including chlamydia and gonorrhea. The gel is based on the same technology as Phexxi and is currently in phase III of clinical trials. Evofem Biosciences also operates a clinical research department focused on reproductive health and oncology, including breast cancer. This research aims to develop new diagnostic procedures and therapies to improve outcomes for women worldwide. Overall, Evofem Biosciences is a company that focuses on the needs of women and holds a leading position in the industry. Since its founding, the company has maintained its focus and goals, successfully developing and bringing innovative products to market over the past 20 years. It is expected that the company will continue to bring products to market in the future that meet the needs of women worldwide and definitively contribute to improving their sexual and reproductive health. Evofem Biosciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Net Income Details

Understanding Evofem Biosciences's Profit Margins

The profit margins of Evofem Biosciences represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Evofem Biosciences's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating Evofem Biosciences's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

Evofem Biosciences's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When Evofem Biosciences’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about Evofem Biosciences stock

How much profit has Evofem Biosciences made this year?

Evofem Biosciences has made -16.37 M USD this year.

How has the profit developed compared to last year?

The profit has increased by -132.75% compared to last year fallen

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does Evofem Biosciences publish its earnings?

Evofem Biosciences publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of Evofem Biosciences?

The profits of Evofem Biosciences are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of Evofem Biosciences?

You can learn more about the earnings of Evofem Biosciences by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does Evofem Biosciences pay?

Over the past 12 months, Evofem Biosciences paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Evofem Biosciences is expected to pay a dividend of 0 USD.

What is the dividend yield of Evofem Biosciences?

The current dividend yield of Evofem Biosciences is .

When does Evofem Biosciences pay dividends?

Evofem Biosciences pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Evofem Biosciences?

Evofem Biosciences paid dividends every year for the past 0 years.

What is the dividend of Evofem Biosciences?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Evofem Biosciences located?

Evofem Biosciences is assigned to the 'Health' sector.

Wann musste ich die Aktien von Evofem Biosciences kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Evofem Biosciences from 11/8/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/8/2024.

When did Evofem Biosciences pay the last dividend?

The last dividend was paid out on 11/8/2024.

What was the dividend of Evofem Biosciences in the year 2023?

In the year 2023, Evofem Biosciences distributed 0 USD as dividends.

In which currency does Evofem Biosciences pay out the dividend?

The dividends of Evofem Biosciences are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Evofem Biosciences

Our stock analysis for Evofem Biosciences Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Evofem Biosciences Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.